Nevertheless, as particularly [99mTc]Tc-N4-asp-[Bta8]MJ9 revealed a favorable biodistribution profile and [99mTc]Tc-MIP-1404 demonstrated high uptake in liver and duodenum in prostate cancer patients, there might be a potential for the GRPR ligand that exhibited improved tumor-to-abdomen contrast preclinically. The gene discussed is GRPR; the disease is Familial prostate cancer.